Join the HotCopper ASX share market forum today for free. Created with Sketch. and as I said I met @Domesticgod there, which was a pleasure. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no deal/licence forthcoming. ZEUS RESOURCES LIMITED. 0¢ Sentiment: Hold Disclosure: Held LikesSPL 7013 is already approved for use in the body (via a mucous membrane) and there would seem to be no issue as regards safety. 5¢. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is differentSPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. Latest Posts. Comments. Merck will fund the research, although Starpharma doesn’t expect the fees to be material, and. . yet if one considers that the amount of millions of shares via option they. Advertise on HotCopper. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. ASX - By Stock. Share Interesting and positive early pre-clinical results. Model # 407730 Store SKU # 1000846365. Last updated 15. 0¢. Discussion. See All Discussions. Target our investor community with our suite of Hotcopper Advertising opportunities. 0. Latest Posts. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Market . 0. My understanding is this condition has not been met however each KMP has received 191,152 rights for this alongside other staff whose allocation will no doubt vary according to the capacity of their employment. Last updated 15. 362771. $1. Market Cap $77. 3¢. Last updated 15. AB you'd better start going out on Friday nights and liveing it up to get in practice for the celebrations when SPL hits the big time! SPL Price at posting: $1. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. 615, today the share price rose by 0. Virtual investor presentation Tomorrow night Starpharma will be Participating in a virtual investorpresentation on the OTC website for those that are. Created with Sketch. “If humans respond in a similar way, the benefits of treatment. Latest Posts. Working in a. ASX - Day Trading. In part it oversees accelerated research initiatives to develop responses to unmet needs. 50 or. Created with Sketch. In summary, my observations about SPL are: Marketing - persistent. . ASX - Day Trading. June 9 (Reuters) - Starpharma Holdings Ltd (SPL) : STARPHARMA CEO TO RETIRE IN 2024 FOLLOWING SIGNIFICANT TENURE AS COMPANY'S CHIEF EXECUTIVE OFFICER. It is lengthy but well worth the time. . Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. Since then. 0000. Volume. Maybe SPL is frustrated at the lack of promotion, or maybe they have frustrated McKesson with continuity of supply, but I doubt it this early in the relationship - the logistics will be guided by demand, and it takes time to find the right equilibrium without overcommitting funds and/or scaling up manufacturing capacity, honouring contracts etc. 0¢. Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. Market . ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. Created with Sketch. Join the HotCopper ASX. 0. The thread is titled so that it can be found and general enough so as to. ASX - Short Term Trading. great news but unlikely. Can you imagine. ASX - By Stock. Created with Sketch. Join the HotCopper ASX share market forum today for free. OR no reponse at all. 0. 47pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on NOVONIX LIMITED. 06B ! Add to my watchlist. Join the HotCopper ASX share. ASX - By Stock. Join the HotCopper ASX share market forum today for free. HotCopper is Australia's largest free and independent stock market trading forum for. Created with Sketch. 0 Great. HotCopper has news, discussion, prices and market data on PROTEOMICS INTERNATIONAL LABORATORIES LTD. ASX - By Stock. Join the HotCopper ASX share market forum today for free. Market. 12. . . Forums. News: SPO Spotless Group To Be Removed From Official List Of ASX Ltd At Close Of Trading On 30 Aug. $-0. Forums. The upper and lower pennant lines will intersect in three months. And somebody must be buying all the shares that are being sold. . This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. 70 Sentiment: Sell Disclosure: HeldNot only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. " Indeed. Announcement on LinkedIn today from Prof David Owen that has left SPL after 15years as VP. 59pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. 36pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on SPARC TECHNOLOGIES LIMITED. Market . Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. ASX - Day TradingSo the share price of SPL rose up to a high of $2. 56am 20/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. I think this is the start of a trail that may lead somewhere in hopefully SPL offering shareholder clearer explainations and referenced articles / posters etc in announcements being on website and then later being unavaliable is a process across the ASX that has to be stopped. 57% 13. ASX - By Stock. Latest Posts. . All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP Cabazitaxel and that isn't until in Q3 CY2023 ,. Yes I think SPL does have a future but TIME is of the essence. Created with Sketch. Thanks for all your hard work and many successes during the year. Twenty years later it’s 84. Advertise on HotCopper. The SP must break out of the. municipal. 5¢. 0000. Last updated 15. Charts. Don’t look to him for the truth lol. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. However, just a word of caution before the usual pumping starts by the usual suspects. One of those is worse that SPL. SUBMISSION STEPS. I have no problem with the way SPL accessed the market initially but percieved issues over time and this may be one. 6. My theory is we had a large accumulator that was content buying. 1029/9/2000 SPL $0. Advertise on HotCopper. HotCopper has news,. Overview. DISCOVER THE BATTERY METALS. Hey, "smart", I concur with your message. Join the HotCopper ASX share market forum today for free. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. Created with Sketch. Over the 3 year period the index has remained at around 40,000 whereas the SPL SP has dropped around 70%. 32 , that is a daily rise of over 50% on the market capital at the time it hit that low. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Last updated 14. Last edited by sarge17: 28/11/22. 0012. Extract taken from recent interview with CEO of Starpharma Does it surprise you that big pharma hasn't come in and swooped in and bought the business to. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. Created with Sketch. It’s incredibly important to keep us informed. Maybe some positive news coming out of Starpharma CEO's busines trip to America over coming daysFor shareholder it is a task of getting a CEO who can make hard decisions based on what does happen but with shrinking internal candidates progress it triggered red flags for me a sif you were very confident and could show progress and efficacy new candidated would and could be funded / partnered so IMO odd to close down or delay. Join the HotCopper ASX share market forum today for free. 0¢. . Share So I am guessing nothing came from the Merck meeting Jackie given they were promoted by name in the Shareholder Update on 3 June as a big meeting to be held on the USA holiday ASCO trip and they have been a 'partner' (and I use that term lightly with this mob) for 10 months longer than Genentech so Merck's research should be much further advanced IMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. The purpose of many of us working in pharmaceutical research and development whether within the industry or academia is to deliver medicines to improve the lives of patients around the world. most else of the list is same as we want to happen years ago and long long overdue. Created with Sketch. 8¢. 367026. Views. SPL Price at posting: 16. Application for quotation of securities - SPL. Canadian Dollar. Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. Both were very well paid and, if the "forward looking statements" are to be believed would have had the box seat in a company with a great future. ASX - Day TradingGood to see another Aussie biotech who has been in communication with the FDA over the last 2 years since receiving a CRL have had their BLA resubmission accepted by the FDA. 5¢. Attached link highlights some of the complexities involved more broadly. ASX - By Stock. Starpharma is listed on the Australian stock exchange (ASX:SPL). 43pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 70% 14. ASX - Day TradingSo ton of quistions to answer for CEO and Board most of them already posed so does she follow past format by putting out an update today that she can. Created with Sketch. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. 4. 3. FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. . J K Fairley $1,272,084N J Baade. I was astounded to see that you Jackie were rewarded with a$200,000 bonus during this time. 36. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Latest Posts. Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. 5¢ Sentiment: Hold Disclosure: HeldThat's so funny col69 Antibotter post had you scrambling to find the link where he got that information then you copy paste the link and infer you knew already, if you did know you would for sure have posted this morning, some posters knew you were not one of them imo, still should have been an announcement let's hope results once collated. Application for quotation of securities - SPL. Latest Posts. ASX - Day Trading SUBMISSION STEPS. 00% 14. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. We had a Dec 2021 DCB of around the FIB 23. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. . Market . And somebody must be buying all the shares that are being sold. The digital display offers a 0. As of 2015, HotCopper was in the top 170 websites in Australia and was. 9¢. But SPL is different, isn't it? SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. . Join the HotCopper ASX share market forum today for free. Created with Sketch. Some links within this article worth a scan too. ASX - Day Trading. 70 Sentiment: Sell Disclosure: Held Not only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and dose escalation apparently continues. 1541401. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. ASX - By Stock. HotCopper has news, discussion, prices and market data on TRIGG MINERALS LIMITED. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. I've been a SPL shareholder since Nov 2015 when I bought a small parcel at 91c. Even Pfizer won’t comment on him. 25. 00 and $5. 199920. . Even if these collaborations have beenterminated, the market deserves to know about it. SPL Price at posting: 91. Last updated 15. Target our investor community with our suite of Hotcopper Advertising opportunities. Target our investor. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be resolved. . distraction achieved. ASX - General. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Ena Respiratory is getting news coverage everywhere - newspapers, onilne, 7 morning news, more coverage than I've seen for SPL - “By boosting the natural immune response of the ferrets with our treatment, we’ve seen a rapid eradication of the virus,” he explained in a statement. Forums. He doesn't "hold" but 99% of his posts are on SPL, including a remarkable 350 in the last two months alone. Created with Sketch. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Join the HotCopper ASX share market forum today for free. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. An expat Indonesian friend did have search for me but didn't find any promotion etc a little while ago. I hope I'm wrong here. , page-2. It is a real eye opener and paints the Pharmaceutical Industry in a very bad light. Starpharma have so far been quite disappointing in the way it has commercialised products The Vivagel condom A dismal failure so far It had been approved. This is just a lifestyle company at this point, management just keeping the company afloat with announcements that have no tangible impact on the share price while they collect their salaries. ASX - By Stock. Created with Sketch. Hope that SPL starts to deliver on its promises. Forex. ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. Forums. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. Charts. 9¢. Become a member of Australia's largest investment discussion forum. Advertise on HotCopper. Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. Join the HotCopper ASX share market forum today for free. . Forums. In SPL's case there is clearly another. ASX - General. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. Latest Posts. I was hoping for. Additionally, three of the companies mentioned that have approved and marketed IO. So SPL have written responses to shareholders saying Viraleze is avaliable under existing exclusive deal with LLoyds but for some unknown reason SPL have developed a " dedicated VIRALEZE™ product UK webstore" and "other online channels" conveniently at a time when LLoyds seem to have destocked stores and webstore no. You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 1. ASX - Day Trading. . IMO they haven't . If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. ACCELERATE RESOURCES LIMITED. And that is my opinion too but about SPL. “It wouldn't surprise me if Starpharma have and are talking with big pharma in a joint collaboration to further develop SPL7013 for other. Join the HotCopper ASX share market forum today for free. 5,006,219 was the total short sales as of 21/07/23 (1. The only double standard I see is that if any employee in the real world repeatedly told their boss that a project would definitely be delivered, every year since 2018 and the project has still not been delivered in early 2023 then they would be ceremoniously SACKED. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. 5¢. We, as investors in this company deserve to knowmore. by other companies i meant those associated with SPL, and ask what up from their end. municipal. Share Great ad I think it will boom in Hong Kong under the Banitore Manning name, despite what the naysayers say Banitore have a big presence in China their manufacturing of health products is also in China I would imagine they have significant pull in China and other regions, In my opinion Viraleze is set to be a huge world product in tome. 0¢. Hey, "smart", I concur with your message. Build your trading strategy and connect with. Market . I find it alarming the number of column inches in the resolution explanatory notes, extolling their experiences prior to spl, when not one of them has any achievements in the advancement of spl listed. Sorry a Faulty Towers and BMC tragic and possibly a SPL one as well . But I’ve been having a. The CEO chose to drop a throwaway line at the end of her presentation to potential investors as reported by Antibotter ie “ Starpharma are pursuing registration in China for Viraleze “ as one of if not the biggest market in the world one would think this is a price sensitive comment after all it was said as bait to potential investors. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 8985. Hey, "smart", I concur with your message. However, just a word of caution before the usual pumping starts by the usual suspects. 37. Just sayin'. ASX - By Stock. LEADING THE BATTERY METALS REVOLUTION. Is this a case of short memories? The best one can say is her surprise is disingenuous. 607432. podcasts, and hotcopper) Reading announcements from Starpharma and having to decipher what is actually being said And finally, lacking the ability to sell our products currently. Investors and the ASX now have their eye on SPL like they normally would have on dodgy mining penny stocks. We would like to show you a description here but the site won’t allow us. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . Some paralllels with SPL, although every product and data is different, but a least MSB are pretty clear with CRL - not pretty fro shareholders and going to take a lot of funding and dillution to achieve trial that could have been completesd in that same timeframe and IMO a lower risk. 3. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. The AGM has come and gone What did we learn from this meeting according to our attendee's who post on HotCopper forum When it comes to. Well done SPL and Scripps Institute. 6% downward extention down to (0. News: SPL Starpharma Holdings Appoints Cheryl Maley As CEO & Managing Director: 10/11/23 : 0: 94: 10/11/23: Last post Hot News: Created with Sketch. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). and I dont like what I am seeing. 5. ASX - Day TradingI will just put it out there that I have been peeved off about our CEO Jackie Fairley and the performance of SPL for a while now. SPL always has tantalising carrots to dangle before the eyes of investors. 15. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". Join the HotCopper ASX share market forum today for free. 57. Last updated 15. Toll free: 1-877-388-4440 Email: CTBTaxQuestions@gov. Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. Created with Sketch. 5¢. Created with Sketch. And it’s at least good to see that the ASX has demanded supplementary information from Starpharma on numerous occasions recently. Latest Posts. More. ASX - General. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. 138. Created with Sketch. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. But the products were developed as proof of a saleable dendrimer product. 0¢. 2. Imo, financial things such as deals, sales and. ASX - By Stock. SPL could announce tomorrow that DEP doesn’t work and they’ll still find a way to spin it positively. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. Forums. ASX - By Stock. Market . S. Join the HotCopper ASX share market forum today for free.